ArsenalBio
Dina Polyak, B. Pharm., Ph.D., is an experienced professional in translational immunology, with a focus on investigating the mechanism of non-small cell lung cancer survival and progression in the brain and cerebrospinal fluid. Dina has utilized innovative methods such as single-cell RNA sequencing and in vivo models to study tumor-glia cell cross-talk. With a background in pharmacology and polymer therapeutics, Dina has also conducted research on complex macromolecules for in vitro delivery and activity in cancer cells. As a former associate lecturer and teaching assistant, Dina has taught pharmacology courses at prestigious medical schools in Israel.
ArsenalBio
ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer.